Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 28, 2026	Feb. 28, 2025	Feb. 28, 2026	Feb. 28, 2025
Sales	$ 3,471,399	$ 14,315,798	$ 21,973,016	$ 39,911,692
Cost of Sales	4,930,543	11,577,980	23,360,699	33,890,446
Gross Profit	(1,459,144)	2,737,818	(1,387,683)	6,021,246
Selling, General and Administrative Expenses	1,202,930	1,374,914	4,190,611	4,556,062
Gain on Involuntary Conversions (Note 4)			0	(741,821)
Operating Income (Loss)	(2,662,074)	1,362,904	(5,578,294)	2,207,005
Other Income (Expense):
Other Income	3,012	45,486	12,400	115,956
Interest Expense	(243,956)	(248,705)	(712,473)	(818,786)
Income (Loss) before Income Taxes	(2,903,018)	1,159,685	(6,278,367)	1,504,175
Benefit (Provision) for Income Taxes	100,940	(194,020)	313,172	(407,770)
Net Income (Loss)	(2,802,078)	965,665	(5,965,195)	1,096,405
Preferred Dividends	0	(115,798)	0	(404,463)
Net Income (Loss) Attributable to Common Stockholders	$ (2,802,078)	$ 849,867	$ (5,965,195)	$ 691,942
Net Earnings (Loss) Per Share of Common Stock -
Basic (in dollars per share)	$ (0.1)	$ 0.03	$ (0.22)	$ 0.02
Diluted (in dollars per share)	$ (0.1)	$ 0.03	$ (0.22)	$ 0.02
Weighted Average Shares of Common Stock Outstanding
Basic (in shares)	27,270,701	28,097,494	27,273,160	28,220,051
Diluted (in shares)	27,270,701	28,592,593	27,273,160	28,715,943
Sales	$ 3,471,399	$ 14,315,798	$ 21,973,016	$ 39,911,692
Cost of Sales	4,930,543	11,577,980	23,360,699	33,890,446
Gross Profit	(1,459,144)	2,737,818	(1,387,683)	6,021,246
Selling, General and Administrative Expenses	1,202,930	1,374,914	4,190,611	4,556,062
Operating Income (Loss)	$ (2,662,074)	$ 1,362,904	$ (5,578,294)	$ 2,207,005